These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
516 related articles for article (PubMed ID: 24063588)
1. The increase of microRNA-21 during lung fibrosis and its contribution to epithelial-mesenchymal transition in pulmonary epithelial cells. Yamada M; Kubo H; Ota C; Takahashi T; Tando Y; Suzuki T; Fujino N; Makiguchi T; Takagi K; Suzuki T; Ichinose M Respir Res; 2013 Sep; 14(1):95. PubMed ID: 24063588 [TBL] [Abstract][Full Text] [Related]
2. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition. Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658 [TBL] [Abstract][Full Text] [Related]
3. Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition. Tang H; He H; Ji H; Gao L; Mao J; Liu J; Lin H; Wu T J Surg Res; 2015 Jul; 197(1):167-75. PubMed ID: 25911951 [TBL] [Abstract][Full Text] [Related]
4. β-catenin induces A549 alveolar epithelial cell mesenchymal transition during pulmonary fibrosis. Song P; Zheng JX; Xu J; Liu JZ; Wu LY; Liu C Mol Med Rep; 2015 Apr; 11(4):2703-10. PubMed ID: 25435076 [TBL] [Abstract][Full Text] [Related]
5. MiR-326-mediated overexpression of NFIB offsets TGF-β induced epithelial to mesenchymal transition and reverses lung fibrosis. Pattnaik B; Negi V; Chaudhuri R; Desiraju K; Faizan MI; Akhtar A; Ansari MS; Shakir M; Gheware A; Prakash YS; Guleria R; Ghosh B; Agrawal A; Ahmad T Cell Mol Life Sci; 2023 Nov; 80(12):357. PubMed ID: 37950757 [TBL] [Abstract][Full Text] [Related]
6. Role of the urokinase-fibrinolytic system in epithelial-mesenchymal transition during lung injury. Marudamuthu AS; Bhandary YP; Shetty SK; Fu J; Sathish V; Prakash Y; Shetty S Am J Pathol; 2015 Jan; 185(1):55-68. PubMed ID: 25447049 [TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase inhibitor restores surfactant protein-C expression in alveolar-epithelial type II cells and attenuates bleomycin-induced pulmonary fibrosis in vivo. Ota C; Yamada M; Fujino N; Motohashi H; Tando Y; Takei Y; Suzuki T; Takahashi T; Kamata S; Makiguchi T; Yamaya M; Kubo H Exp Lung Res; 2015; 41(8):422-34. PubMed ID: 26151196 [TBL] [Abstract][Full Text] [Related]
8. Nintedanib reduces ventilation-augmented bleomycin-induced epithelial-mesenchymal transition and lung fibrosis through suppression of the Src pathway. Li LF; Kao KC; Liu YY; Lin CW; Chen NH; Lee CS; Wang CW; Yang CT J Cell Mol Med; 2017 Nov; 21(11):2937-2949. PubMed ID: 28598023 [TBL] [Abstract][Full Text] [Related]
9. Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway. Ji Y; Dou YN; Zhao QW; Zhang JZ; Yang Y; Wang T; Xia YF; Dai Y; Wei ZF Acta Pharmacol Sin; 2016 Jun; 37(6):794-804. PubMed ID: 27133302 [TBL] [Abstract][Full Text] [Related]
11. M2 macrophages induce EMT through the TGF-β/Smad2 signaling pathway. Zhu L; Fu X; Chen X; Han X; Dong P Cell Biol Int; 2017 Sep; 41(9):960-968. PubMed ID: 28493530 [TBL] [Abstract][Full Text] [Related]
12. Ligand-independent transforming growth factor-β type I receptor signalling mediates type I collagen-induced epithelial-mesenchymal transition. DeMaio L; Buckley ST; Krishnaveni MS; Flodby P; Dubourd M; Banfalvi A; Xing Y; Ehrhardt C; Minoo P; Zhou B; Crandall ED; Borok Z J Pathol; 2012 Mar; 226(4):633-44. PubMed ID: 21984393 [TBL] [Abstract][Full Text] [Related]
13. Regulation of Transforming Growth Factor-β/Smad-mediated Epithelial-Mesenchymal Transition by Celastrol Provides Protection against Bleomycin-induced Pulmonary Fibrosis. Divya T; Velavan B; Sudhandiran G Basic Clin Pharmacol Toxicol; 2018 Aug; 123(2):122-129. PubMed ID: 29394529 [TBL] [Abstract][Full Text] [Related]
14. Hydrogen inhalation attenuated bleomycin-induced pulmonary fibrosis by inhibiting transforming growth factor-β1 and relevant oxidative stress and epithelial-to-mesenchymal transition. Gao L; Jiang D; Geng J; Dong R; Dai H Exp Physiol; 2019 Dec; 104(12):1942-1951. PubMed ID: 31535412 [TBL] [Abstract][Full Text] [Related]
15. Inhibition and role of let-7d in idiopathic pulmonary fibrosis. Pandit KV; Corcoran D; Yousef H; Yarlagadda M; Tzouvelekis A; Gibson KF; Konishi K; Yousem SA; Singh M; Handley D; Richards T; Selman M; Watkins SC; Pardo A; Ben-Yehudah A; Bouros D; Eickelberg O; Ray P; Benos PV; Kaminski N Am J Respir Crit Care Med; 2010 Jul; 182(2):220-9. PubMed ID: 20395557 [TBL] [Abstract][Full Text] [Related]
16. Deficiency of CARMA3 attenuates the development of bleomycin induced pulmonary fibrosis. Wu Y; Qi Y; Qiu Z; Chen W Biochem Biophys Res Commun; 2021 Dec; 581():81-88. PubMed ID: 34656852 [TBL] [Abstract][Full Text] [Related]
17. 1α,25-dihydroxyvitamin D3 Attenuates TGF-β-Induced Pro-Fibrotic Effects in Human Lung Epithelial Cells through Inhibition of Epithelial-Mesenchymal Transition. Jiang F; Yang Y; Xue L; Li B; Zhang Z Nutrients; 2017 Sep; 9(9):. PubMed ID: 28878195 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of Wnt/β-catenin signaling suppresses bleomycin-induced pulmonary fibrosis by attenuating the expression of TGF-β1 and FGF-2. Chen X; Shi C; Meng X; Zhang K; Li X; Wang C; Xiang Z; Hu K; Han X Exp Mol Pathol; 2016 Aug; 101(1):22-30. PubMed ID: 27112840 [TBL] [Abstract][Full Text] [Related]
19. Epithelial-mesenchymal transition involved in pulmonary fibrosis induced by multi-walled carbon nanotubes via TGF-beta/Smad signaling pathway. Chen T; Nie H; Gao X; Yang J; Pu J; Chen Z; Cui X; Wang Y; Wang H; Jia G Toxicol Lett; 2014 Apr; 226(2):150-62. PubMed ID: 24530353 [TBL] [Abstract][Full Text] [Related]